Score Breakdown
Offering Ability
40
Cash Runway—
Float Risk
14
Warrant Exposure
40
Convertible Debt
40
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split
model est. 55%
• 50-day avg $0.36 below $1 exchange minimum
Market Data
Market Cap$366.18M
Shares Outstanding1.08B
Float835.88M
Cash$7.11M
Debt$2.37M
Short InterestN/A
Institutional Holdings
1 institutional holders · 500 shares
#1
KELLEHER FINANCIAL ADVISORS
500 shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest2.69M
Days to Cover3.7
% of Float0.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2023-12-31
xbrl
XBRL CONVERTIBLE
2017-03-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual ELTP Dilution Snapshot
Elite Pharmaceuticals, Inc. (ELTP) has a DilutionScore of 24/100, rated Low dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for ELTP: xbrl on 2023-12-31; xbrl on 2017-03-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — LOW Risk
Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles: